Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Singh B, Dopkins N, Fei T, Marston JL, Michael S, Reyes-Gopar H, et al. Locus specific human endogenous retroviruses reveal new lymphoma subtypes. bioRxiv. 2023.

Boyraz B, Post MD, Hasserjian RP, Oliva E. Follicular Dendritic Cell Sarcoma of Uterine Corpus: Report of 2 Cases. Int J Gynecol Pathol. 2023;42(4):390-397.

Simner PJ, Bard JD, Doern C, J Johnson K, Westblade L, Yenokyan G, et al. Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures. Clin Infect Dis. 2023;76(9):1550-1558.

Petersen J, Du W, Adkisson C, Gravekamp C, Oktay MH, Condeelis J, et al. Stabilized Window for Intravital Imaging of the Murine Pancreas. J Vis Exp. 2023;(200).

Hao Y, Lynch K, Fan P, Jurtschenko C, Cid M, Zhao Z, et al. Development of a Machine Learning Algorithm for Drug Screening Analysis on High-Resolution UPLC-MSE/QTOF Mass Spectrometry. J Appl Lab Med. 2023;8(1):53-66.

Liu D, Cheng Y, Zhou H, Wang L, Fiel RH, Gruenstein Y, et al. Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA. Emerg Infect Dis. 2023;29(2):371-380.

Barone P, Patel S. Myelodysplastic syndrome: Approach to diagnosis in the era of personalized medicine. Semin Diagn Pathol. 2023;40(3):172-181.

Callum J, Bégin P, Jamula E, Liu Y, Kron AT, Auclair M-, et al. Lessons learned from the CONCOR-1 trial. Transfus Med. 2023;33(1):21-25.

Alhomoud M, Magro C, Seshan S, Zhang T, Gomez-Arteaga A, Chokr N, et al. Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone Marrow Transplant. 2023;58(11):1270-1274.

Pan E, Xie W, Ajmera A, Araneta A, Jamieson C, Folefac E, et al. A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Mol Cancer Ther. 2023;22(4):511-518.